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The cardiac steroid ouabain, a known inhibitor of the sodium pump (Na+,K+-ATPase), has been shown to release endothelin from endothelial
cells when used at concentrations below those that inhibit the pump. The present study addresses the question of which signaling pathways are
activated by ouabain in endothelial cells. Our findings indicate that ouabain, applied at low concentrations to human umbilical cord endothelial
cells (HUAECs), induces a reaction cascade that leads to translocation of endothelial nitric oxide synthase (eNOS) and to activation of
phosphatidylinositol 3-kinase (PI3K). These events are followed by phosphorylation of Akt (also known as protein kinase B, or PKB) and
activation of eNOS by phosphorylation. This signaling pathway, which results in increased nitric oxide (NO) production in HUAECs, is inhibited
by the PI3K-specific inhibitor LY294002. Activation of the reaction cascade is not due to endothelin-1 (ET-1) binding to the ET-1 receptor B
(ETB), since application of the ETB-specific antagonist BQ-788 did not have any effect on Akt or eNOS phosphorylation. The results shown here
indicate that ouabain binding to the sodium pump results in the activation of the proliferation and survival pathways involving PI3K, Akt
activation, stimulation of eNOS, and production of NO in HUAECs. Together with results from previous publications, the current investigation
implies that the sodium pump is involved in vascular tone regulation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Na+,K+-ATPase; Ouabain; Signaling cascade; Akt; eNOs; PI3K1. Introduction
The Na+,K+-ATPase has been known for almost 50 years as
the enzyme that transports 3 sodium ions out of the cell and 2
potassium ions into the cell for each ATP hydrolyzed. This
activity, however, which is specifically inhibited by cardiac
glycosides like ouabain, does not seem to be the only property
of the enzyme. Strong evidence has accumulated in recent years
pointing towards a receptor–hormone interaction between the
enzyme and its cardiac glycoside inhibitors when these are used
at rather low concentrations [1,2]. These interactions result in
the stimulation of various intracellular signaling cascades that
include extracellular signal-regulated kinase (ERK) 1/2 activa-
tion [3–6], Ca2+ oscillations [6,7], translocation of nuclear⁎ Corresponding author. Institut für Biochemie und Endokrinologie, Fachber-
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doi:10.1016/j.bbamem.2006.09.006factors to the nucleus [7], or stimulation of cell proliferation
[6,8].
In a recent study, we demonstrated that ouabain, used at
concentrations below those needed for global sodium pump
inhibition, stimulates the release of endothelin-1 (ET-1) from
human umbilical artery endothelial cells (HUAECs) [6].
Nevertheless, endothelial cells not only produce ET-1 but also
the vasorelaxant nitric oxide (NO). Therefore, the focus of the
work presented here was to investigate whether NO production
by HUAECs might be stimulated by low concentrations of
ouabain and, if so, to identify the signaling cascade involved in
this stimulation.
2. Materials and methods
2.1. Isolation and culture of HUAECs
Human umbilical cords were collected within 2 h of birth and kept on ice in
wash buffer [Hanks buffered salt solution (HBSS) containing 20 mm N-2-
hydroxypiperazin-N′-2-ethanesulfonic acid (HEPES)] until ready for cell
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collagenase (CLS 2, Worthington, UK) in Pucks saline solution (Seromed,
Berlin, Germany) containing 20 mM HEPES, and incubated at 37 °C for 20 min
to detach the endothelium. The cells were washed out using 20–50 ml wash
buffer containing 10% fetal calf serum (FCS) and centrifuged at 50×g, 4 °C for
10 min. The cell pellet was suspended in 10 ml endothelial cell growth medium
(ECGM; Promocell, Heidelberg, Germany) and transferred to a gelatin-coated,
94 mm cell culture dish. After 4 h, the medium containing any nonadherent cells
was aspirated and the medium was replaced. During culture at 37 °C under 5%
CO2, the medium was replaced every 48 h. After the first passage, ECGM was
mixed with M199 (Gibco, Eggenstein, Germany) to give a 2:1 ratio,
respectively, with an additional 2% FCS supplement (ECGM-2).
2.2. Preparation of cell lysates
HUAECs were plated at a density of 5×106 cells in culture dishes of 10 cm
diameter and were grown to confluence as described above. The cells were then
serum-starved (i.e. 0.5% serum) in a 2:1 M199:ECGM (basal medium) mixture
(ECGM-SF) for 24 h before commencing the experiment.
Ouabain was added to the cells at various concentrations in ECGM-SF and
the cells were further incubated at 37 °C for 30 min. The cells were then lysed
using a commercially available cell lysis buffer (Cell Signaling Technology,
Frankfurt, Germany) according to the protocol of the provider. The lysis buffer
contained 20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM
EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate,
1 mM Na3VO4, μg/ml leupeptin. Immediately before use, 1 μM PMSF was
added to the lysis buffer. All lysis steps were carried out on ice. After
centrifugation of the lysates at 4 °C for 15 min at 13,000×g, the protein in the
supernatant was determined using the bicinchoninic acid (BCA) protein assay
reagent kit (Pierce, Rockford, IL) by including the lysis buffer also in the
standard. Aliquots were stored at −20 °C.
2.3. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and elec-
trotransfer of isolated proteins
Proteins of the cell lysates were separated by SDS-PAGE using slab gels of
10% acrylamide and 0.3% N,N′-methylene-bis-acrylamide [9]. A total of 10 μg
of protein was run on each lane. Biotinylated and pre-stained molecular weight
markers (Cell Signaling Technology, Frankfurt, Germany) were run in parallel.
After the electrophoretic separation, proteins were electro-blotted onto
nitrocellulose membranes (Schleicher and Shull, Dassel, Germany) at 10 V
for 30 min.
2.4. Immunodetection of Akt
Phosphorylated Akt was detected in a Western blot using a polyclonal
antibody raised in rabbit (Cell Signaling Technology) specifically recognizing
the phosphorylated Ser473 of the enzyme. In all cases, the protocols of the
providers were followed. Overall Akt protein was detected by a specific
polyclonal immunoglobulin (Cell Signaling Technology).
After electrotransfer, incubation with either of the antibodies was carried out
by following the protocol recommended by the provider. The visualization of the
phosphorylated or nonphosphorylated Akt was performed by using the
appropriate horseradish peroxidase-conjugated IgG (1:2000 in TBS-T contain-
ing 5% nonfat milk) provided by the enhanced chemiluminescence (ECL) kit
(Amersham-Pharmacia). A horseradish peroxidase-conjugated anti-biotin IgG
(Cell Signaling Technology) to detect the molecular weight marker was also
included in the incubation medium at a dilution of 1:2000. After film exposure,
bands were relatively quantified using a digital documentation system (Biostep,
Jahnsdorf, Germany) and the Phoretix TotalLab gel image analysis software
(Biostep).
2.5. Ouabain-induced translocation of endothelial nitric-oxide
synthase (eNOS)
HUAECs were grown as described above and were serum-starved for
24 h before commencing the experiment. Ouabain (10 nM) was added to eachdish and the incubation continued for various times. The first time point was
taken at 1 min, since this is the time required for removing the medium and
washing the cells. Afterwards cell lysates were prepared as described above.
Proteins were separated by electrophoresis and subsequently blotted onto a
nitrocellulose membrane as described above. Membranes were then incubated
overnight at 4 °C in TBS-T/5% BSA. A polyclonal antibody against eNOS
raised in rabbits (Cell Signaling Technology) was added at a 1:1500 dilution
to the solution and incubation was continued for another 90 min. The
immunoreactive bands were detected by the by ECL kit (Amersham-
Pharmacia) as described above.
2.6. Immunodetection of phosphorylated eNOS
The conditions for SDS-PAGE and for electrotransfer of the proteins are the
same as above. The primary polyclonal antibody (Cell Signaling Technology)
raised in rabbits recognizes the phosphorylated Ser1177 of eNOS. The dilution
used was 1:1000 in TBS-Tcontaining 5% nonfat dry milk. All further incubation
steps followed the protocol of the provider. Detection of the immunoreactive
proteins was accomplished using the ECL kit (Amersham-Pharmacia). The
abundance of phosphorylated eNOS was measured by the digital documentation
system and the Phoretix TotalLab gel image analysis software mentioned above
(Biostep).
2.7. Nitric oxide (NO) detection
HUAECs were grown as described above. After 24 h in serum-free
medium (i.e. 0.5% FCS), cells were washed twice with phosphate-buffered
saline (PBS). Thereafter, cells were incubated at 37 °C, 5% CO2 for 60 min
in 2 ml of PBS containing 100 μM L-arginine and 1 μM 4,5-
diaminofluorescein diacetate (DAF-2 DA; Merck Biosciences, Schwalbach,
Germany). The latter compound is taken up by the cell and becomes
converted to DAF-2 by intracellular esterases. At physiological pH, DAF-2 is
relatively nonfluorescent. In the presence of NO and O2, however, DAF-2 is
converted to the fluorescent DAF-2 triazole (DAF-2T), which displays a 180-
fold increase in fluorescence quantum efficiency over DAF-2 [10,11].
Ouabain (10 nM) was then added and incubation was continued for a further
30 min. For the negative control, ouabain was omitted. In order to inhibit NO
production, some samples contained besides 10 nM ouabain also 10 μM NG-
nitro-L-arginine methyl ester (L-NAME; Sigma, Dassel, Germany). The effect
of L-NAME on basal NO production was also measured in the absence of
ouabain.
After incubation, the supernatant was removed and cells were washed twice
with phosphate buffered saline (PBS) and subsequently suspended in 2 ml of the
commercially available lysis buffer under the conditions mentioned above.
Following centrifugation at 13,000×g for 15 min at 4 °C, supernatants were
collected for fluorescence spectroscopy. The pellets were used for the BCA
protein assay (Pierce, Rockford, IL).
Fluorescence was measured in a Hitachi spectral fluorimeter at an excitation
wavelength of 485 nm and an emission wavelength of 538 nm. The fluorescence
obtained in the absence of ouabain was set to account for 100%.
2.8. Effect of an endothelin B (ETB) receptor antagonist and a
phosphatidylinositol 3-kinase (PI3K) inhibitor on Akt and eNOS
phosphorylation
In order to investigate the involvement of the ETB receptor in the cascade
leading to Akt and eNOS activation, HUAECs were used which had been grown
and serum-starved for 24 h as described above. Either at the beginning of serum
starvation or just for the last 2 h of this period, the highly specific ETB antagonist
BQ-788 (Alexis Biochemicals, Grünberg/Germany) was added to the medium at
a concentration of 10 μM. Ouabain was added afterwards to a final
concentration of 10 nM and incubation continued for an additional 30 min.
Thereafter, cell lysates were collected as described above and were investigated
for phospho-Akt and phospho-eNOS immunoreactivity.
To assess the potential role of PI3K in this pathway, the same experiment
was performed with the exception that the PI3K inhibitor LY294002 (50 μM;
Cell Signaling Technology) was used in place of BQ-788.
Fig. 2. Time course of Akt activation. (A) The abundance of total Akt in the cell
lysates is not influenced by 10 nM ouabain. (B) Under the same conditions,
ouabain stimulates Akt phosphorylation over a period of 60 min. Control
proteins were isolated after 60 min from HUAECs that were not incubated with
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3.1. Immunodetection of activated (phosphorylated) and total
Akt
Akt (also called PKB) is a protein kinase that plays a crucial
role in controlling the balance between cell survival and
apoptosis [7,12]. After 30 min of incubation, ouabain at low
concentrations ranging between 0.1 and 10 nM stimulated Akt
phosphorylation as detected by the use of an antibody that
specifically recognizes the phosphorylated Ser473 of the
enzyme (Fig. 1A). The molecular weight of the detected
phosphorylated protein is 60 kDa, which corresponds to the
expected relative molecular mass of Akt. In the absence of
ouabain, no phosphorylated Akt was detected. The difference in
the amount of phosphorylated Akt detected was not due to
variation in the total Akt protein (Fig. 1B). The experiment also
shows that the presence of ouabain does not influence the total
amount of Akt in the cells.
The time course of the Akt phosphorylation was examined
by incubating HUAECs for various times with 10 nM ouabain.
While the total Akt in the supernatant of the cell lysates was not
influenced by ouabain (Fig. 2A), ouabain stimulated Akt
phosphorylation in a time-dependent manner (Fig. 2B). In the
experiment shown here, after 30 min the phosphorylationFig. 1. Activation of Akt by ouabain. (A) Proteins from cell lysates from
HUAECs were isolated after ouabain incubation for 30 min and blotted after
SDS-PAGE onto nitrocellulose. The activated Akt was visualized by using a
polyclonal antibody raised in rabbit against the phosphorylated Akt and, as a
secondary antibody, a horseradish peroxide-conjugated anti-IgG of the ECL kit.
(B) Visualization of total Akt. Blots shown are representative of results shown in
several separate experiments. (C) Densitometric analysis of the bands shown in
A and from 3 other experiments (n=4; ±SEM) with density in corresponding
control bands (total Akt) set to 100. Data were analyzed by one-way ANOVA
using the GraphPad-Prism software (GraphPad Software Inc, San Diego, CA)
(*p<0.05 versus control).
ouabain but otherwise treated identically. (C) Densitometric analysis of the
bands shown in panel B and from 2 other experiments (n=3; ±SEM) with
density in control band set to 100. (mwm=molecular weight markers).reached a maximum that was 3-fold higher than the phosphor-
ylation level after 1 min. On the average, phosphorylation was
more than 2-fold higher after 30 min (Fig. 2C). After another
30 min, the phosphorylation level was somewhat reduced, but
still 2.5-fold higher than the phosphorylation at 1 min.
3.2. Akt-catalyzed phosphorylation of eNOS
Endothelial NO synthase (eNOS) is directly regulated by
Akt, which phosphorylates the enzyme at Ser1177 [13]. Since
ouabain activates Akt by phosphorylation, it was important to
determine whether ouabain treatment would also result in eNOS
phosphorylation in the HUAECs.
Treatment of HUAECs for 30 min with various concentra-
tions of ouabain resulted in eNOS phosphorylation as revealed
by SDS-PAGE and Western blotting (Fig. 3). Since very little
phosphorylated eNOS was found in the absence of ouabain, the
stronger signals obtained at 0.1, 1, and 10 nM ouabain can be
attributed to ouabain action (Fig. 3B). At 0.1 nM ouabain,
activation was 118±8% above control and reached a maximum
of 139±7% above control at 10 nM ouabain (n=3; ±SEM). The
total amount of eNOS was the same in all samples (Fig. 3A).
3.3. Ouabain-induced eNOS translocation
eNOS is localized at the inner surface of the plasma
membrane in an inactive, caveolin-associated form [14].
Increased intracellular [Ca2+] causes Ca2+/calmodulin to bind
Fig. 5. Effect of the ETB receptor antagonist BQ-788 on Akt and eNOS
phosphorylation. (A) A total of 10 μM BQ-788 applied to HUAECs 2 h before
the addition of 10 nM ouabain did not influence ouabain-induced Akt
phosphorylation. A 24-h incubation with BQ-788 did not alter the result (not
shown). (B) Similarly, ouabain-induced eNOS phosphorylation was not
inhibited by BQ-788 under the same conditions. Blots shown are representative
of two experiments conducted similarly.
Fig. 3. Ouabain-induced stimulation of eNOS phosphorylation. A) Total eNOS.
B) Preincubation of HUAECs for 30 min with various concentrations of ouabain
stimulates eNOS, as determined using a rabbit antibody that recognizes the
phosphorylated Ser1177 of eNOS. Under these conditions, no apparent
differences were seen in phosphorylation levels obtained by ouabain at 0.1, 1,
or 10 nM. All three concentrations, however, clearly stimulated eNOS
phosphorylation above control levels (0 nM ouabain). Blots shown are
representative of three experiments conducted similarly.
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intracellular compartments and initiates NO production [14,15].
Since ouabain has been shown to cause intracellular [Ca2+]
elevation in various cells including HUAECs [6,7,16], we were
interested to investigate whether the cardiac glycoside would
induce any changes in the content of eNOS protein in the cell
lysates prepared from HUAECs. In contrast to the previous
experiment shown in Fig. 3, where various concentrations of
ouabain were used for the same time of 30 min, here we
incubated the cells with 10 nM ouabain for 0, 1, 5, 15, 30 and
60 min. As determined by SDS-PAGE of proteins from cell
lysates of HUAECs followed by Western blotting for eNOS,
there was a clear ouabain-induced, time-dependent transloca-
tion of eNOS from the Triton-insoluble (caveolar) to a Triton-
soluble fraction (Fig. 4A). Most of the protein translocated
within the first 15 min (Fig. 4B).Fig. 4. Ouabain-induced translocation of eNOS. Membranes were probed with
anti-eNOS antibodies as described in Materials and methods. (A) A total of
10 nM ouabain added to HUAECs caused the time-dependent translocation of
eNOS. Control proteins were isolated after 60 min from HUAECs that had not
been incubated with ouabain. (B) Densitometric analysis of the results in panel
A and from 2 other experiments (n=3; ±SEM) with density set in control band
to 100.3.4. Effect of the ETB receptor antagonist BQ-788 and of the
PI3K inhibitor LY294002 on Akt or eNOS phosphorylation
Binding of ET-1 to the ETB receptor of the endothelial cells
stimulates Akt and eNOS phosphorylation [17]. Since ouabain
induces the exocytosis of ET-1 from HUAECs [6], we
investigated a possible involvement of this receptor in the
ouabain-induced stimulation of Akt and eNOS phosphorylation
seen here by using the ETB receptor-specific antagonist BQ-
788. Neither Akt (Fig. 5A) nor eNOS phosphorylation (Fig. 5B)
was inhibited by 10 μM BQ-788 [18], suggesting that the
observed ouabain-induced activation of Akt and eNOS is not
mediated through the ETB receptor. In contrast to BQ-788, the
PI3K inhibitor LY294002 at 50 μM [19] fully suppressed the
ouabain-induced eNOS or Akt phosphorylation (Fig. 6),
pointing to an important role of PI3K in the activation of
these enzymes by ouabain.
3.5. Stimulation of NO production by ouabain
Endothelial cells regulate vascular tone by producing either
the vasoconstrictive ET-1 or the vasodilatory NO [20].
Treatment of HUAECs with ouabain resulted in an increase in
NO production (Fig. 7). Although ouabain-induced stimulationFig. 6. Inhibition of ouabain-induced phospho-Akt and phospho-eNOS
formation by the PI3K inhibitor LY294002. A total of 50 μM LY294002 was
added to the HUAECs culture 2 h before the addition of 10 nM ouabain. This led
to the inhibition of ouabain-induced phospho-Akt and phospho-eNOS
formation. Blots shown are representative of two experiments conducted
similarly.
Fig. 7. Stimulation of NO production by ouabain. Ouabain stimulated NO
formation by HUAECs as detected by the fluorogenic substrate DAF-2. For the
control, ouabain was omitted. This value was taken to represent 100% NO
formation. Ouabain-stimulated NO production was inhibited by 10 μM L-
NAME to a level below the 100% value of the control (n=3; ±SEM). Data were
analyzed by one way ANOVA using the GraphPad-Prism software (*p<0.05
versus control).
Fig. 8. A schematic summary of the ouabain effects observed in this
investigation. Ouabain (OU) binding to the sodium pump (SP) leads to
stimulation of phosphatidylinositol 3-kinase (PI3K), which activates Akt by
phosphorylation. This enzyme then phosphorylates eNOS and stimulates the
enzyme to produce NO. In nature, this reaction possibly counteracts the ouabain-
induced ET-1 release observed in a previous investigation [6]. The mechanism
by which ouabain stimulates eNOS translocation, possibly from caveolae, are
not yet understood.
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detected in unstimulated cells. The NO synthesis inhibitor L-
NAME [21] at 10 μM inhibited the ouabain-stimulated NO
production even below the level of that obtained in the absence
of ouabain. Similarly, L-NAME reduced NO production in
ouabain-untreated cells below the NO production of the control.
4. Discussion
Recent investigations demonstrate that the role of the
mammalian sodium pump is not only associated with the ion
pumping process that contributes to the maintenance of the
membrane potential and sodium gradient; they clearly show the
involvement of the enzyme in communicating its interactions
with ouabain and other cardiac steroids into the cytosol and
nucleus by activating a variety of tissue-specific cell signaling
cascades [1,2].
In endothelial cells, at concentrations that do not cause a
global inhibition of the sodium pump [6], ouabain was shown to
induce Ca2+ oscillations and ET-1 release within minutes after
application. Since ET-1-induced vasoconstriction is often
counterbalanced by NO-induced vasodilatation [17,22], we
investigated whether ouabain at low concentrations stimulates
NO production in HUAECs. The results shown here support
this hypothesis. The current investigation unveils that the
reaction cascade induced by ouabain follows a known signal
transduction pathway that includes activation of PI3K, Akt
activation by phosphorylation at Ser473, eNOS phosphoryla-
tion at Ser 1177 and, finally, increased production of NO (Fig.
8). In a recent investigation it was shown that the bradykinin-
stimulated increase of NO production in rat endothelial cells
was augmented by ouabain [23]. It is likely that ouabain triggers
the same reaction cascade in these cells as in the HUAECs,
which then leads to elevated NO production.
Activation of eNOS is described in the literature to occur by
different pathways: Akt-dependent phosphorylation and Ca2+-
induced translocation of the protein from the membrane-boundstate to intracellular compartments [14,24,25]. In our experi-
ments, the involvement of the Akt-dependent pathway was
demonstrated by the abolition of eNOS phosphorylation by the
use of the PI3K-specific inhibitor LY294002. Nevertheless, we
also observed a strong, ouabain-induced translocation of eNOS
from a Triton-insoluble (caveolar) to Triton-soluble fraction
(Fig. 4). As shown earlier, this might be due to ouabain-induced
Ca2+ elevation in HUAECs [6]. Nevertheless, while transloca-
tion of eNOS from the plasma membrane to intracellular
compartments has been described to be associated with
activation [24], in our experiments the level of phosphorylated
eNOS does not correspond to the total amount of eNOS
detected (Fig. 4). The detection of phosphorylated eNOS is
rather difficult since the enzyme seems to be a target of very
active phosphatases [26]. Thus, in most investigations phos-
phorylated eNOS is demonstrated shortly after applying a
substance that stimulates enzyme phosphorylation. We assume
that the detected enzyme is probably transiently phosphory-
lated and active before it is rapidly dephosphorylated by
phosphatases.
How does ouabain and its interaction with the sodium pump
lead to the PI3K activation, Akt and eNOS phosphorylation,
and NO production? Since ouabain induces ET-1 release from
HUAECs [6], one possibility would be via ET-1 binding to the
ETB receptor that is localized in the membrane of HUAECs
[17]. Although this pathway might have a small contribution to
the effects seen, it cannot play a major role in the ouabain-
induced stimulation of NO production because the addition of
the ETB receptor-specific antagonist BQ-788 did not influence
Akt or eNOS phosphorylation. Thus, there must be a different
mechanism by which the cardiac steroid confers the information
to the intracellular milieu via its binding to the sodium pump.
1814 A. Eva et al. / Biochimica et Biophysica Acta 1758 (2006) 1809–1814Most likely this mechanism involves a direct binding of PI3K to
the sodium pump. PI3K has been previously shown to directly
interact with the sodium pump by its binding to a proline-rich
motif of the Na+,K+-ATPase α subunit [27].
At the current stage, our working model is that the binding of
ouabain to the sodium pump confers a signal via PI3K that then
turns on the proliferation and survival pathways involving Akt
and stimulating eNOS and NO production in HUAECs. In a
living organism, this reaction cascade might be a measure for
counterbalancing the effects of endothelin-1, whose release from
HUAECs was shown earlier to be stimulated by ouabain [6].
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